Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 26.

Kündig, T M; Klimek, L; Schendzielorz, P; Renner, W A; Senti, G; Bachmann, M F (2015). Is the allergen really needed in allergy immunotherapy? Current Treatment Options in Allergy, 2:72-82.

Zaleska, A; Eiwegger, T; Soyer, O; van de Veen, W; Rhyner, C; Soyka, M B; Bekpen, C; Demiröz, D; Treis, A; Söllner, S; Palomares, O; Kwok, W W; Rose, H; Senti, G; Kündig, T M; Ozoren, N; Jutel, M; Akdis, C A; Crameri, R; Akdis, M (2014). Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Allergy, 69(9):1162-1170.

Graf, N; Dinkel, B; Rose, H; Hothorn, L A; Gerhard, D; Johansen, P; Kundig, T M; Klimek, L; Senti, G (2014). A critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trials. Rhinology, 52(2):137-141.

Uermösi, C; Zabel, F; Manolova, V; Bauer, M; Beerli, R R; Senti, G; Kündig, T M; Saudan, P; Bachmann, M F (2014). IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization. Allergy, 69(3):338-347.

Klimek, L; Willers, J; Schendzielorz, P; Kündig, T M; Senti, G (2013). Immuntherapie der allergischen Rhinitis ohne Allergene? : Neue Möglichkeiten einer Immunmodulation durch Vakzinierung mittels „virus-like particles“ und CpG-Motiven. HNO, 61(10):826-833.

von Moos, S; Johansen, P; Waeckerle-Men, Y; Mohanan, D; Senti, G; Häffner, A; Kündig, T M (2012). The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy. Allergy, 67(5):638-646.

Fettelschoss, A; Kistowska, M; LeibundGut-Landmann, S; Beer, H D; Johansen, P; Senti, G; Contassot, E; Bachmann, M F; French, L E; Oxenius, A; Kündig, T M (2011). Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression. Proceedings of the National Academy of Sciences of the United States of America, 108(44):18055-18060.

Kündig, T M; Johansen, P; Senti, G (2011). Intralymphatic vaccination. In: Rappuoli, R; Bagnoli, F. Vaccine design: innovative approaches and novel strategies. Norfolk, UK: Caister Academic Press, 211-224.

Senti, G; Freiburghaus, A U; Kündig, T (2011). Coated textiles and the skin. In: McCarthy, B J. Textiles for hygiene and infection control. Cambridge, UK: Woodhead Publishing, 186-195.

Senti, G; von Moos, S; Kündig, T M (2011). Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? Allergy, 66(6):798-809.

Senti, G; Johansen, P; Kündig, T M (2011). Intralymphatic immunotherapy: from the rationale to human applications. In: Valenta, R; Coffman, R L. Vaccines against Allergies. Berlin Heidelberg: Springer, 71-84.

Tay, F; Senti, G; Althaus, B (2011). Klinische Forschung in der Schweiz – die Rolle der Clinical Trial Units. Schweizerische Ärztezeitung, 92(50):1966-1969.

von Moos, S; Kündig, T M; Senti, G (2011). Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy. Immunology and Allergy Clinics of North America, 31(2):391-406.

Speiser, D E; Schwarz, K; Baumgaertner, P; Conzett, K B; Manolova, V; Devevre, E; Sterry, W; Walden, P; Zippelius, A; Senti, G; Voelter, V; Cerottini, J P; Guggisberg, D; Willers, J; Geldhof, C; Romero, P; Kündig, T; Knuth, A; Dummer, R; Trefzer, U; Bachmann, M F (2010). Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. Journal of Immunotherapy, 33(8):848-858.

Tay, F; Kündig, T M; Senti, G (2010). Allergenspezifische Immuntherapie: Auf neuen Wegen in die Zukunft. Praxis, 99(21):1279-1284.

Senti, G; Freiburghaus, A U; Kundig, T M (2010). Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials. Current Opinion in Allergy and Clinical Immunology, 10(6):582-586.

Johansen, P; Wäckerle-Men, Y; Senti, G; Kündig, T M (2010). Nickel sensitisation in mice: a critical appraisal. Journal of Dermatological Science, 58(3):186-192.

Senti, G; Johansen, P; Kündig, T M (2009). Intralymphatic immunotherapy. Current Opinion in Allergy and Clinical Immunology, 9(6):537-43.

Senti, G; Graf, N; Haug, Susanne; Rüedi, N; von Moos, S; Sonderegger, T; Johansen, P; Kündig, T M (2009). Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. Journal of Allergy and Clinical Immunology, 124(5):997-1002.

Senti, G; Johansen, P; Haug, Susanne; Bull, C; Gottschaller, C; Müller, P; Pfister, T; Maurer, P; Bachmann, M F; Graf, N; Kündig, T M (2009). Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clinical and Experimental Allergy, 39(4):562-570.

Martínez-Gómez, J M; Johansen, P; Rose, H; Steiner, M; Senti, G; Rhyner, C; Crameri, R; Kündig, T M (2009). Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy, 64(1):172-178.

Martínez-Gómez, J M; Johansen, P; Erdmann, I; Senti, G; Crameri, R; Kündig, T M (2009). Intralymphatic injections as a new administration route for allergen-specific immunotherapy. International Archives of Allergy and Immunology, 150(1):59-65.

Mantinez-Gomez, J M; Johansen, P; Erdmann, I; Senti, G; Crameri, R; Kündig, T M (2009). Intralymphatic injections as a new prospective administration route for allergen-specific immunotherapy. International Archives of Allergy and Immunology, 150(1):59-65.

Senti, G; Prinz Vavricka, B M; Erdmann, I; Diaz, M I; Markus, R; McCormack, S J; Simard, J J; Wüthrich, B; Crameri, R; Graf, N; Johansen, P; Kündig, T M (2008). Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(46):17908-17912.

Johansen, P; Storni, T; Rettig, L; Qiu, Z; Der-Sarkissian, A; Smith, K A; Manolova, V; Lang, K S; Senti, G; Müllhaupt, B; Gerlach, T; Speck, R F; Bot, A M; Kündig, T M (2008). Antigen kinetics determines immune reactivity. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(13):5189-5194.

Johansen, P; Senti, G; Maria Martínez Gómez, J; Kündig, T M (2008). Medication with antihistamines impairs allergen-specific immunotherapy in mice. Clinical and Experimental Allergy, 38(3):512-519.

This list was generated on Mon Nov 20 07:50:21 2017 CET.